Abstract
The current TNM staging for oropharyngeal cancer (OSCC) was designed empirically for non-HPV-related disease. Emerging evidence suggests it is unsuited for Human papillomavirus (HPV)-related OSCC. Patients with HPV-positive tumors have improved prognosis, despite presenting at advanced stages. These shortcomings of the current staging system have been identified in single- and multi-institutional trials. Patients with HPV related OSCC typically present with advanced N-stages leading to higher stage groupings. A rarity of stages I and II therefore represents the nature of HPV-related OSCC. Concerning prognosis of the patients, N-category and extracapsular spread seem to be of minor importance, whereas advanced T-stages result in unfavourable outcome. Anatomical staging therefore has been implied into different proposals to prognostic risk classifications in HPV-related disease as an additive compound. Prognostic risk groupings are further enhanced by incorporating non-anatomical factors. To summarize, it can be suggested that the current TNM system alone has little prognostic value in HPV-related OSCC.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Ang KK et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363(1):24–35
Argiris A et al (2008) Head and neck cancer. Lancet 371(9625):1695–1709
Edge SB, Compton CC (2010) The American joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6):1471–1474
Frakes JM et al (2016) Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer. Cancer 122(4):634–641
Goldenberg D et al (2008) Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck 30(7):898–903
Granata R et al (2012) Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study. Ann Oncol 23(7):1832–1837
Hafkamp HC et al (2009) P21 Cip1/WAF1 expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosis. Mod Pathol 22(5):686–698
Haughey BH, Sinha P (2012) Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer. Laryngoscope 122(Suppl 2):S13–S33
Hong AM et al (2010) Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy. Br J Cancer 103(10):1510–1517
Huang SH et al (2015) Refining American joint committee on cancer/union for international cancer control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas. J Clin Oncol 33(8):836–845
Jain KS et al (2013) Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer. Cancer 119(10):1832–1837
Keane FK et al (2015) Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era. Cancer 121(15):2594–2602
Klozar J et al (2013) Nodal status is not a prognostic factor in patients with HPV-positive oral/oropharyngeal tumors. J Surg Oncol 107(6):625–633
Klussmann JP et al (2003) Human papillomavirus-positive tonsillar carcinomas: a different tumor entity? Med Microbiol Immunol 192(3):129–132
Langendijk JA et al (2005) Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy. Cancer 104(7):1408–1417
Lindel K et al (2001) Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer 92(4):805–813
Porceddu SV et al (2011) Results of a prospective study of positron emission tomography-directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapy. Head Neck 33(12):1675–1682
Rahmati R et al (2015) Squamous cell carcinoma of the tonsil managed by conventional surgery and postoperative radiation. Head Neck 37(6):800–807
Rietbergen MM et al (2013) Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials. Ann Oncol 24(11):2740–2745
Rietbergen MM et al (2015) Different prognostic models for different patient populations: validation of a new prognostic model for patients with oropharyngeal cancer in Western Europe. Br J Cancer 112(11):1733–1736
Rios Velazquez E et al (2014) Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging. Radiother Oncol 113(3):324–30
Setton J et al (2015) A multi-institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity-modulated radiotherapy. Cancer 121(2):294–301
Sinha P et al (2012) Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma. Cancer 118(14):3519–3530
Smith EM et al (2004) Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 108(5):766–772
Thompson LD, Heffner DK (1998) The clinical importance of cystic squamous cell carcinomas in the neck: a study of 136 cases. Cancer 82(5):944–956
Ward MJ et al (2015) Staging and treatment of oropharyngeal cancer in the human papillomavirus era. Head Neck 37(7):1002–1013
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Wittekindt, C., Klussmann, J.P. (2017). Tumor Staging and HPV-Related Oropharyngeal Cancer. In: Golusiński, W., Leemans, C., Dietz, A. (eds) HPV Infection in Head and Neck Cancer. Recent Results in Cancer Research, vol 206. Springer, Cham. https://doi.org/10.1007/978-3-319-43580-0_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-43580-0_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43578-7
Online ISBN: 978-3-319-43580-0
eBook Packages: MedicineMedicine (R0)